Company Filing History:
Years Active: 2023-2025
Title: Innovations by Inventor Felipe Varum
Introduction
Felipe Varum is a notable inventor based in Rheinfelden, Switzerland. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of solid dosage forms. With a total of three patents to his name, Varum's work focuses on improving drug delivery systems.
Latest Patents
One of Varum's latest patents is titled "Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and spheronization." This invention relates to a method for preparing immediate and sustained release solid dosage forms that include antibodies and their functional fragments. The process involves wet granulation, extrusion, and spheronization, with an optional delayed release coating. The solid dosage forms produced by this method are intended for topical treatment in the gastrointestinal tract of patients.
Another significant patent is the "Method of producing a delayed release drug formulation." This method creates a coatable core for a delayed release drug formulation intended for oral administration, specifically designed to deliver a drug to the colon. The process includes forming a core containing the drug and coating it with an outer layer made from a combination of an enzymatically degradable polymer and a film-forming enteric polymer.
Career Highlights
Felipe Varum is currently associated with Tillotts Pharma AG, a company known for its innovative pharmaceutical solutions. His work at Tillotts Pharma AG has allowed him to focus on developing advanced drug formulations that enhance therapeutic efficacy.
Collaborations
Varum collaborates with talented professionals in his field, including Laetitia Von Rochow and Roberto Bravo. These collaborations contribute to the innovative environment at Tillotts Pharma AG, fostering the development of cutting-edge pharmaceutical technologies.
Conclusion
Felipe Varum's contributions to pharmaceutical innovations through his patents demonstrate his commitment to advancing drug delivery systems. His work continues to impact the field positively, enhancing treatment options for patients.